A young researcher takes over a refrigerator full of bacteria. Eleven years later, he sells his company for up to 450 million Swiss francs – how is that possible?

Simon Ittig, former ETH researcher, sold his biotech startup after 11 years for up to CHF 450 million. He developed an innovative cancer treatment from bacteria. His success story prompts reflection on entrepreneurship in the Swiss research landscape and how knowledge can be transformed into…